Transport of recombinant hirudin across xenopus pulmonary membrane

Chinese Pharmaceutical Journal

Volumn 40, Issue 17, 2005, Pages 1318-1322

  Liu, Yu ^a   Lu, Wan Liang ^a   Hu, Xin ^a   Zhang, Hua ^a   Zhang, Xuan ^a   Wang, Xue Qing ^a   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Mechanism; Pulmonary absorption; Recombinant hirudin; Transport; Xenopus pulmonary membrane

Indexed keywords

ABSORPTION; FLUORESCENCE; PH EFFECTS; TISSUE; TRANSPORT PROPERTIES;

MECHANISM; PULMONARY ABSORPTION; TRANSPORT;

MEMBRANES;

HIRUDIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFUSION; DRUG TRANSPORT; ENERGY; FLUORESCENCE; LUNG ALVEOLUS EPITHELIUM; MEMBRANE TRANSPORT; NONHUMAN; OSMOTIC PRESSURE; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE; XENOPUS;

EID: 28444474585     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Markwardt F. Past, present and future of hirudin[J]. Haemostasis, 1991, 21(Suppl 1):11.
2. Yan XY, Wang X, Zhang Q. Gastrointestinal absorption of recombinant hirudin-2 in rats[J]. J Pharmacol Exp Ther, 2004, 308 (2): 774.
3. Todo H, OkamatoH, Iida K, et al. Effect of additives on insulin absorption from intratracheally administered dry powders in rats[J]. Int J Pharm, 2001, 220(1-2):101.
4. Ban E, Ryu J, Yoo YS. Detection of recombinant hirudin using capillary electrophoresis with laser-induced fluorescence detection[J]. Microchem J, 2001, 70(3):211.
5. Stone SR, Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin[J]. Biochemistry, 1986, 25(16):4622.
6. Chang JY. Stability of hirudin, a thrombin-specific inhibitor[J]. J Biol Chem, 1991, 266(17):10839.
7. Liu Y, Lu WL, Zhang Q, et al. Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes[J] Peptides, 2005, 26:423.
8. Patton JS. Mechanism of macromolecule absorption by the lung[J]. Adv Drug Del Rev, 1996, 9(1):3.
9. Wall DA, Pierdomenico D, Wilson G. An in vitro pulmonary system for evaluating peptide transport[J]. J Controlled Release, 1993, 24 (1):227.
10. Okumura S, Fukuda Y, Yamamoto A. Transport of drugs across the xenopus pulmonary membrane and their absorption enhancement by various absorption enhancers[J]. Pharm Res, 1993, 13(8):1247.
11. Yamamoto A, Tanaka H, Okumura S, et al. Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using xenopus pulmonary membrane[J]. Biol Pharm Bull, 2001, 24 (4):385.
12. Wang ZY, Zhang Q. Transport of proteins and peptides across human cultured alveolar A549 cell monolayer[J]. Int J Pharm, 2004, 269 (2):451.
13. 14C] albumin transport across bullfrog alveolar epithelium[J]. J Appl Physiol, 1985, 59(4):1290.
14. Skakgami M, Byron PR, Rypacek F. Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lungs: effects of temperature and metabolic inhibitors[J]. J Pharm Sci, 2002, 91 (9):1958.
15. + transport by cultured monolayers of pulmonary alveolar epithelial cells [J]. Am J Physiol, 1983, 245(1):C78.
16. Kim KJ, Crandall ED. Effects of exposure to acid on alveolar epithelial water and solute transport[J]. J Appl Physiol, 1982, 52(4):902.